Browse Guides  internal medicine  haematology  anticoagulation

Warfarin

Starting treatment
Indications
Dosing and monitoring
Complications
Follow-up
Complications

Unexpected bleed at therapeutic levels of INR

Investigate for underlying malignancy (look for gastrointestinal and genitourinary especially). b  

Why?

  • Diagnostic evaluation of gastrointestinal bleeding and gross haematuria may lead to the diagnosis of previously unknown lesions in one third of patients - half have malignancy b
  • The most common sites of bleeding for patients on heparin or warfarin are the gastrointestinal tract, the urinary tract, soft tissues, the oropharynx. b

Soft tissue or wounds are the commonest bleeding sites

Site b heparin warfarin
soft tissue/ wound 31% 21%
GI tract 27% 15%
urinary tract 19% 15%
nasopharynx 6% 35%
intracranial 2% 4%
retroperitoneal 3% 1%

Expiry date: May 2003
Levels of Evidence used in grading these guides

With thanks to Drs. David Keeling, John Reynolds, David Sackett, Sharon Straus and Alan Townsend 
for use of their anticoagulation guide on which this one is based.

Author   CM   Ball
Reviewer   A   Gallus
CAT Writer   CM   Ball